Morinamide
Chemical compound
- J04AK04 (WHO)
- BR: Class A1 (Narcotic drugs)[1]
- N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide
- 952-54-5
- 70374
- 63555
- 8CFL28PA3W
- D07248
Y
- DTXSID4046159
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- C1COCCN1CNC(=O)C2=NC=CN=C2
InChI
- InChI=1S/C10H14N4O2/c15-10(9-7-11-1-2-12-9)13-8-14-3-5-16-6-4-14/h1-2,7H,3-6,8H2,(H,13,15)
- Key:GVTLAVKAVSKBKK-UHFFFAOYSA-N
Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.[2] It behaves as a prodrug for Pyrazinamide.
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.
- v
- t
- e
Rifamycins/ RNA polymerase inhibitor | |
---|---|
Antifolates/DSI | |
ASA | |
Topoisomerase inhibitors/ quinolones |
Aminoglycosides | |
---|---|
Oxazolidone | |
Polypeptide antibiotics |
Peptidoglycan layer |
|
---|---|
Arabinogalactan layer |
|
Mycolic acid layer |
|
- Phenazine (Clofazimine)#
- Pyrazine (Pyrazinamide#, Morinamide)
- Isoxazole (Terizidone)
- Bedaquiline
- Nitroimidazole (Delamanid, Pretomanid)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e